Keith Danahey
University of Chicago(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Pharmaceutical studies and practices, Pharmaceutical Practices and Patient Outcomes, Genomics and Rare Diseases, COVID-19 Clinical Research Studies
Most-Cited Works
- → The 1200 Patients Project: Creating a New Medical Model System for Clinical Implementation of Pharmacogenomics(2012)177 cited
- → Adoption of a clinical pharmacogenomics implementation program during outpatient care–initial results of the University of Chicago “1,200 Patients Project”(2014)128 cited
- → T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells.(1995)93 cited
- → Pharmacogenomics‐Based Point‐of‐Care Clinical Decision Support Significantly Alters Drug Prescribing(2017)86 cited
- → COVIDOSE: A Phase II Clinical Trial of Low‐Dose Tocilizumab in the Treatment of Noncritical COVID‐19 Pneumonia(2020)59 cited
- → Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs(2015)50 cited
- → Simplifying the use of pharmacogenomics in clinical practice: Building the genomic prescribing system(2017)47 cited
- → Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study(2018)32 cited
- → Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program(2016)31 cited
- → Impact of CYP2D6 Pharmacogenomic Status on Pain Control Among Opioid-Treated Oncology Patients(2021)28 cited